Loading…
← CockpitCompetitor Analysis › ARTEMISMED.NS Artemis Medicare Services Ltd.Open in the cockpit ↗

Artemis Medicare Services Ltd.ARTEMISMED.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Hospital/Nursing Management
Momentum leader 85
Mkt cap
$582M
US dollars, full cap
Free float
20%
of shares outstanding
$/day
$653,765
20-day average traded
Fwd P/E
42.3×
forward earnings
ROIC−WACC
-9.0 pp
WACC 20.0%
Hurdle
+27 pp
Req g minus delivered
Next earnings
88 days
14 Feb 2027
Close · INR₹343.40
1D-1.5%
1W+9.5%
1M+14.0%
3M+10.0%
6M+24.8%
YTD+26.7%
1Y+27.7%
ATR %3.7%
Beta0.74
52w lowhigh9.3% off high

What Artemis Medicare Services does

Employees: 2,076

Artemis Medicare Services at a glance

Size Artemis Medicare Services (ARTEMISMED.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $582M, the 799th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹343.40 on 18 Nov 2026.

Performance Over six months the shares gained 24.8%, against -5.6% for the median peer and +3.8% for the India market (cap-weighted) — 3rd highest of 19 in its peer set.

Growth Revenue grew 14.8% over the last twelve months (peer median +10.9%); the operating margin is 13.5% (peer median 10.2%).

Valuation It trades at 42.3× forward earnings against a peer median of 20.5× (3rd most expensive of 14).

Price implies For today's price to make sense, revenue must grow about 48% a year for seven years (Req g). Recent delivered growth is +22%, so the hurdle is +27 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 9.0 points below its cost of capital (20.0% WACC).

Next results Next results expected around 14 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026ARTEMISMED.NS 123Peer median 93
Six months, rebased to 100: Artemis Medicare Services against the median of its 20 peers (local-currency closes).

Artemis Medicare Services financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹11.5B₹10.8B₹9.36B₹8.77B₹7.37B
Revenue growth—+15%+7%+19%—
Gross profit₹2.34B₹1.90B₹1.54B₹1.37B₹1.04B
EBITDA₹2.07B₹1.90B₹1.55B₹1.34B₹958M
Net income₹1.15B₹1.04B₹826M₹491M₹386M
Free cash flown/a₹322M₹492M₹124M-₹338M
Capital expendituren/a₹1.05B₹932M₹726M₹1.46B
Total debt₹3.24B₹2.62B₹2.90B₹3.20B₹2.86B

Quarterly statements and history in the cockpit →

Artemis Medicare Services competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%+40%GHCKOVAI6062VOX15153012392609A50HCGINDRAMEDCOGDSJLHLVMDQC7RHKPARKHOSPSARTEMISMED.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Artemis Medicare Services is the large dot.

Fundamentals: revenue growth against valuation

0%+5%+10%+15%+20%0×25×50×75×GHC6062VOX1515301239HCGINDRAMEDCOCBAVJLHLVMDQC7PARKHOSPSARTEMISMED.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Artemis Medicare Services is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%GHCKOVAI6062VOX15153012392609A50INDRAMEDCOGDSKMCSHIL301103CBAVVMDPARKHOSPSARTEMISMED.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Artemis Medicare Services is the large dot.

Artemis Medicare Services competitors and peer comparison

How Artemis Medicare Services compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Artemis Medicare Services against its 20 peers (data as of 18 Nov 2026)
MeasureARTEMISMED.NSPeer medianRank in peer set
1-month return+14.0%-2.1%4th highest of 20
6-month return+24.8%-5.6%3rd highest of 19
Distance from 52-week high-9.3%-22.3%6th highest of 21
Revenue growth (TTM)+14.8%+10.9%8th highest of 21
Operating margin13.5%10.2%8th highest of 21
Forward P/E42.3×20.5×3rd most expensive of 14
Growth the price implies (Req g, 7 yrs)48.5%6.5%most demanding of 17
Growth delivered (Del g)+21.5%+15.5%3rd highest of 17
Hurdle (Req g minus delivered)+26.9 pp-7.1 ppmost demanding of 17
ROIC minus cost of capital-9.0 pp+1.1 pp2nd lowest of 21
EV / EBITDA26.5×12.9×5th most expensive of 18
Net debt / EBITDA0.3×0.6×9th least indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%42.3×48.5%+21.5%
Garofalo Health Care GHC.MIItaly$508M-3%+4%10%20.5×1.7%+18.3%
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%n/a17.4%+18.1%
Charm Care 6062.TJapan$402M+57%+6%11%15.3×-0.4%+16.4%
Voxel VOX.WAPoland$393M+59%+14%24%13.6×1.2%+12.2%
China Resources Medical 1515.HKHong Kong$393M-10%0%6%5.4×-7.5%+26.3%
Bright Eye Hospital 301239.SZChina$377M-26%+11%9%41.5×-5.1%+15.5%
Bayzed Health 2609.HKHong Kong$375M-58%-2%5%n/a14.7%+9.2%
Thomson Medical A50.SISingapore$923M-18%+6%10%n/a21.2%+11.8%
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%88.8×n/an/a
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%n/an/an/a
Indraprastha Medical INDRAMEDCO.NSIndia$351M0%+11%15%15.9×14.9%+19.3%
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%n/a6.1%+6.0%
KMC Speciality Hospitals (India) KMCSHIL.NSIndia$346Mn/a+35%23%n/a19.0%+24.4%
Liaoning He Eye Hospital 301103.SZChina$342M-20%+3%4%n/a-4.2%+5.4%
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%20.1×2.3%+19.7%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%48.8×n/an/a
Viemed Healthcare VMDUnited States$333M-9%+22%8%17.4×6.8%+15.5%
Q & M Dental Group (Singapore) QC7.SISingapore$326M-26%+16%9%31.6×7.7%+7.5%
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%22.5×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%30.6×22.1%+10.2%

Questions

Which companies are Artemis Medicare Services's closest peers?
The cockpit's peer set: Garofalo Health Care (GHC.MI), Kovai Medical Center & Hospital (KOVAI.NS), Charm Care (6062.T), Voxel (VOX.WA), China Resources Medical (1515.HK), Bright Eye Hospital (301239.SZ), Bayzed Health (2609.HK), Thomson Medical (A50.SI).
Is Artemis Medicare Services expensive compared with its peers?
On forward p/e it trades at 42.3× against a peer median of 20.5×, 3rd most expensive of 14 in its peer set. For today's price to make sense, revenue must grow about 48% a year for seven years (Req g). Recent delivered growth is +22%, so the hurdle is +27 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Artemis Medicare Services stock performed?
Over six months to 18 Nov 2026 the shares returned +24.8% against -5.6% for the median peer; over one year +27.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.